These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 26775242)
1. Ready-to-use colloidal adjuvant systems for intranasal immunization. Lee JJ; Shim A; Lee SY; Kwon BE; Kim SR; Ko HJ; Cho HJ J Colloid Interface Sci; 2016 Apr; 467():121-128. PubMed ID: 26775242 [TBL] [Abstract][Full Text] [Related]
2. Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice. Shahiwala A; Amiji MM J Drug Target; 2008 May; 16(4):302-10. PubMed ID: 18446609 [TBL] [Abstract][Full Text] [Related]
3. Curdlan sulfate- Zhang S; Huang S; Lu L; Song X; Li P; Wang F Int J Nanomedicine; 2018; 13():2377-2394. PubMed ID: 29713168 [TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001 [TBL] [Abstract][Full Text] [Related]
5. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines. Patel GB; Zhou H; Ponce A; Chen W Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279 [TBL] [Abstract][Full Text] [Related]
6. Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice. Patel GB; Ponce A; Zhou H; Chen W J Liposome Res; 2008; 18(2):127-43. PubMed ID: 18569448 [TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity. Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114 [TBL] [Abstract][Full Text] [Related]
11. Role of T cells in the adjuvant effect of Bacillus firmus on the immune system of mice: intranasal and intratracheal immunization study with ovalbumin. Mlcková P; Cechová D; Marusková L; Chalupná P; Novotná O; Prokesová L Folia Microbiol (Praha); 2003; 48(3):427-34. PubMed ID: 12879759 [TBL] [Abstract][Full Text] [Related]
12. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles? Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518 [TBL] [Abstract][Full Text] [Related]
13. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice. Howe SE; Konjufca VH PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518 [TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization. Liu Q; Zhang C; Zheng X; Shao X; Zhang X; Zhang Q; Jiang X Vaccine; 2014 May; 32(22):2582-90. PubMed ID: 24681230 [TBL] [Abstract][Full Text] [Related]
15. The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant. Libanova R; Ebensen T; Schulze K; Bruhn D; Nörder M; Yevsa T; Morr M; Guzmán CA Vaccine; 2010 Mar; 28(10):2249-2258. PubMed ID: 20060510 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity. Bento D; Staats HF; Gonçalves T; Borges O Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119 [TBL] [Abstract][Full Text] [Related]
17. Fabrication of chitosan-based emulsion as an adjuvant to enhance nasal mucosal immune responses. Li D; Li W; Li S; Zhang Y; Hu X; Liu S; Li Y Int J Biol Macromol; 2024 Jun; 272(Pt 2):132913. PubMed ID: 38851606 [TBL] [Abstract][Full Text] [Related]
18. Intratracheal and intranasal immunization with ovalbumin conjugated with Bacillus firmus as a carrier in mice. Mlcková P; Polácek M; Cechová D; Marusková L; Stanková I; Chalupná P; Novotná O; Julák J; Prokesová L Folia Microbiol (Praha); 2005; 50(3):247-53. PubMed ID: 16295664 [TBL] [Abstract][Full Text] [Related]
19. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987 [TBL] [Abstract][Full Text] [Related]
20. House dust extracts have both TH2 adjuvant and tolerogenic activities. Ng N; Lam D; Paulus P; Batzer G; Horner AA J Allergy Clin Immunol; 2006 May; 117(5):1074-81. PubMed ID: 16675335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]